| (19) |
 |
|
(11) |
EP 3 461 845 A8 |
| (12) |
CORRECTED EUROPEAN PATENT APPLICATION |
|
Note: Bibliography reflects the latest situation |
| (15) |
Correction information: |
|
Corrected version no 1 (W1 A1) |
| (48) |
Corrigendum issued on: |
|
29.05.2019 Bulletin 2019/22 |
| (43) |
Date of publication: |
|
03.04.2019 Bulletin 2019/14 |
| (22) |
Date of filing: 12.12.2014 |
|
| (51) |
International Patent Classification (IPC):
|
|
| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA ME |
| (30) |
Priority: |
13.12.2013 US 201361916087 P
|
| (62) |
Application number of the earlier application in accordance with Art. 76 EPC: |
|
14824269.6 / 3080164 |
| (71) |
Applicant: Genentech, Inc. |
|
South San Francisco, CA 94080 (US) |
|
| (72) |
Inventors: |
|
- Yu, Shang-Fan
South San Francisco, CA 94080 (US)
- Liang, Wei -Ching
South San Francisco, CA 94080 (US)
- Wu, Yan
South San Francisco, CA 94080 (US)
- Leong, Steven
South San Francisco, CA 94080 (US)
- Polson, Andrew
South San Francisco, CA 94080 (US)
|
| (74) |
Representative: Mewburn Ellis LLP |
|
City Tower
40 Basinghall Street
London EC2V 5DE
London EC2V 5DE (GB) |
|
| |
|
|
|
Remarks: |
|
This application was filed on 31-10-2018 as a divisional application to the application
mentioned under INID code 62. |
|
| (54) |
ANTI-CD33 ANTIBODIES AND IMMUNOCONJUGATES |
(57) The disclosure provides anti-CD33 antibodies and immunoconjugates and methods of
using the same.